Required information [The following information applies to the questions displayed below.J The December 31, 2018, unadjusted trial balance for the Wolkstein Drug Company is presented below. December 31 is the company's fiscal year-end Debits Account Title Cash Accounts receivable Prepaid rent Inventory Equipment Accumulated depreciation-equipment Accounts payable Salaries and wages payable Common stock Retained earnings Sales revenue Cost of goods sold Salaries and wages expense Rent expense Depreciation expense Utility expense Advertising expense Credits 70,918 23,000 2,800 35,000 66,000 19,808 24,000 100,000 16,000 373,000 223,800 74,680 16,800 14,920 4,970 532,800 Totals 532,800 The following year-end adjusting entries are required a. Depreciation expense for the year on the equipment is $6,600 b. Accrued salaries and wages payable at year-end should be $4,880